Atıf Formatları
The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

G. G. Jones Et Al. , "The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors.," AACR Special Conference on Targeting RAS-Driven Cancers , vol.18, California, United States Of America, pp.65-66, 2018

Jones, G. G. Et Al. 2018. The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors.. AACR Special Conference on Targeting RAS-Driven Cancers , (California, United States Of America), 65-66.

Jones, G. G., Del Rio, I. B., Sari, S., Sekerim, A., Young, L. C., Hartig, N., ... El-Bahrawy, M. A.(2018). The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors. . AACR Special Conference on Targeting RAS-Driven Cancers (pp.65-66). California, United States Of America

Jones, Greg Et Al. "The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors.," AACR Special Conference on Targeting RAS-Driven Cancers, California, United States Of America, 2018

Jones, Greg G. Et Al. "The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors.." AACR Special Conference on Targeting RAS-Driven Cancers , California, United States Of America, pp.65-66, 2018

Jones, G. G. Et Al. (2018) . "The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors.." AACR Special Conference on Targeting RAS-Driven Cancers , California, United States Of America, pp.65-66.

@conferencepaper{conferencepaper, author={Greg G. Jones Et Al. }, title={The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors.}, congress name={AACR Special Conference on Targeting RAS-Driven Cancers}, city={California}, country={United States Of America}, year={2018}, pages={65-66} }